Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis... Show more
a biopharmaceutical company
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HWTIX | 11.23 | 0.09 | +0.81% |
| Hotchkis & Wiley Intl Sm Cp Dvsfd Val I | |||
| FDETX | 26.79 | 0.20 | +0.75% |
| Fidelity Advisor Capital Development O | |||
| PGTRX | 70.82 | 0.18 | +0.25% |
| Putnam Global Technology R | |||
| FGNCX | 12.45 | N/A | N/A |
| Nuveen Global Infrastructure C | |||
| TMCLX | 8.90 | -0.01 | -0.11% |
| Transamerica Energy Infrastructure C | |||
A.I.dvisor indicates that over the last year, IMRN has been closely correlated with LABFF. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMRN jumps, then LABFF could also see price increases.
| Ticker / NAME | Correlation To IMRN | 1D Price Change % | ||
|---|---|---|---|---|
| IMRN | 100% | -1.60% | ||
| LABFF - IMRN | 81% Closely correlated | N/A | ||
| MNMD - IMRN | 44% Loosely correlated | -2.82% | ||
| VYGR - IMRN | 26% Poorly correlated | -0.34% | ||
| CELZ - IMRN | 25% Poorly correlated | -5.02% | ||
| TCRX - IMRN | 24% Poorly correlated | -5.41% | ||
More | ||||